Welcome to Demei Chemical Technology Co., Ltd
📞 +86-0536-2205782 📧 arron.seagulls@gmail.com
Language: English | Japanese | Russian

Pentobarbital sodium salt

CAS No.: 57-33-0

  • Molecular Formula: C₁₁H₁₇N₂NaO₃
  • Molecular Weight: 248.25 g/mol

Chemical type

  • Barbiturate
[1]
  • Barbiturate anesthetic
  • Central nervous system depressant
[2]

Key properties

  • Short-acting anesthetic and sedative
[1]
  • Induces anesthesia
  • Used for animal surgical procedures
  • Acts on GABA-A receptors
  • Rapid onset sedative
[2]
  • Anesthetic for animal procedures (e.g., echocardiography in rats)
[1]
  • Anesthetic in animal experiments
  • Used during liver ischemia–reperfusion surgery
[2]

Classification by use

  • Anesthetics and sedatives (veterinary/experimental)
[1]
  • Chemicals used as anesthetics
  • Chemicals used in animal surgical models
  • Chemicals used for central nervous system depression
[2]

A trustworthy factory and manufacturer

Demei Chemical Technology Co., Ltd. is a modern high-tech enterprise integrating R&D, production, and sales. The company's founder, Dr. Arron, born in April 1975, graduated from the School of Mechanical Engineering at Yanshan University and has been engaged in research in the fields of mechanical engineering and chemical synthesis for many years. The company's products focus on the chemical industry, primarily dealing in chemical raw materials and chemical production machinery and equipment. With its strong technical capabilities, advanced production equipment, and strict quality management system, the company has earned the trust of customers worldwide.

  1. [Cite:1] ANKRD1 knockdown attenuates doxorubicin-induced dilated cardiomyopathy by regulating mitochondrial dysfunction and oxidative stress through activation of the AMPK/AKT/mTOR pathway, Electronic Journal of Biotechnology, Volume 79, January 2026, 100696
  2. [Cite:2] CTGF regulated by ATF6 inhibits vascular endothelial inflammation and reduces hepatic ischemia–reperfusion injury, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, Volume 1870, Issue 8, December 2024, 167490